Targeting Heat Shock Protein 27 and Fatty Acid Oxidation Augments Cisplatin Treatment in Cisplatin-Resistant Ovarian Cancer Cell Lines

Most ovarian cancer patients develop recurrent cancers which are often resistant to commonly employed chemotherapy agents, such as cisplatin. We have previously shown that the inhibition of heat shock protein 27 (HSP27) or fatty acid oxidation (FAO) sensitizes cisplatin-resistant ovarian cancer cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Heiserman, James Patrick, Minhas, Zenab, Nikpayam, Elahe, Cheon, Dong-Joo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454186/
https://www.ncbi.nlm.nih.gov/pubmed/37628819
http://dx.doi.org/10.3390/ijms241612638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454186/
https://www.ncbi.nlm.nih.gov/pubmed/37628819
http://dx.doi.org/10.3390/ijms241612638

Ejemplares similares